

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte development (GO:0003334) | 6.69171596 |
| 2 | intestinal epithelial cell development (GO:0060576) | 5.95700871 |
| 3 | negative regulation of JUN kinase activity (GO:0043508) | 5.85916350 |
| 4 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.83787623 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.79779202 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.79779202 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.37785436 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.37785436 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.74029848 |
| 10 | RNA destabilization (GO:0050779) | 4.50013434 |
| 11 | protein K11-linked deubiquitination (GO:0035871) | 4.43273223 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.31115738 |
| 13 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.24543533 |
| 14 | intestinal cholesterol absorption (GO:0030299) | 4.23765808 |
| 15 | cysteine metabolic process (GO:0006534) | 4.18372144 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.18080310 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.02923353 |
| 18 | lactate metabolic process (GO:0006089) | 4.00017296 |
| 19 | bile acid biosynthetic process (GO:0006699) | 3.93136239 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.90074899 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.90074899 |
| 22 | tryptophan catabolic process (GO:0006569) | 3.90074899 |
| 23 | negative regulation of acute inflammatory response (GO:0002674) | 3.87451579 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 3.87357102 |
| 25 | glyoxylate metabolic process (GO:0046487) | 3.83772052 |
| 26 | platelet dense granule organization (GO:0060155) | 3.79966991 |
| 27 | DNA deamination (GO:0045006) | 3.75659155 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75210121 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 3.73492598 |
| 30 | regulation of hexokinase activity (GO:1903299) | 3.72434558 |
| 31 | regulation of glucokinase activity (GO:0033131) | 3.72434558 |
| 32 | tryptophan metabolic process (GO:0006568) | 3.71320515 |
| 33 | kynurenine metabolic process (GO:0070189) | 3.71201577 |
| 34 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.69899549 |
| 35 | regulation of respiratory burst (GO:0060263) | 3.66614492 |
| 36 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65362054 |
| 37 | protein carboxylation (GO:0018214) | 3.59652854 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.59652854 |
| 39 | triglyceride homeostasis (GO:0070328) | 3.52257345 |
| 40 | acylglycerol homeostasis (GO:0055090) | 3.52257345 |
| 41 | positive regulation of protein autophosphorylation (GO:0031954) | 3.51955528 |
| 42 | lysine metabolic process (GO:0006553) | 3.50975581 |
| 43 | lysine catabolic process (GO:0006554) | 3.50975581 |
| 44 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.50401564 |
| 45 | T-helper cell differentiation (GO:0042093) | 3.50401564 |
| 46 | urea cycle (GO:0000050) | 3.45719108 |
| 47 | urea metabolic process (GO:0019627) | 3.45719108 |
| 48 | bile acid metabolic process (GO:0008206) | 3.44806497 |
| 49 | regulation of protein glycosylation (GO:0060049) | 3.44210361 |
| 50 | reverse cholesterol transport (GO:0043691) | 3.43453612 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 3.41256458 |
| 52 | tyrosine metabolic process (GO:0006570) | 3.39454752 |
| 53 | regulation of cholesterol esterification (GO:0010872) | 3.38385614 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 3.35745904 |
| 55 | regulation of fibroblast apoptotic process (GO:2000269) | 3.35105002 |
| 56 | homocysteine metabolic process (GO:0050667) | 3.34216884 |
| 57 | cellular glucuronidation (GO:0052695) | 3.34089659 |
| 58 | aromatic amino acid family metabolic process (GO:0009072) | 3.33163517 |
| 59 | short-chain fatty acid metabolic process (GO:0046459) | 3.32789981 |
| 60 | fibroblast migration (GO:0010761) | 3.30375121 |
| 61 | molting cycle (GO:0042303) | 3.28549241 |
| 62 | hair cycle (GO:0042633) | 3.28549241 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 3.27601770 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 3.26220334 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 3.25540865 |
| 66 | complement activation, alternative pathway (GO:0006957) | 3.23804479 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 3.22464636 |
| 68 | macromolecular complex remodeling (GO:0034367) | 3.22464636 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.22464636 |
| 70 | fatty acid oxidation (GO:0019395) | 3.20979157 |
| 71 | * positive regulation of mRNA catabolic process (GO:0061014) | 3.20276799 |
| 72 | ethanol oxidation (GO:0006069) | 3.19918984 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 3.19862656 |
| 74 | phospholipid efflux (GO:0033700) | 3.18808383 |
| 75 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.18095608 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.17254440 |
| 77 | lipid oxidation (GO:0034440) | 3.16515142 |
| 78 | response to nitrosative stress (GO:0051409) | 3.15805651 |
| 79 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.14593486 |
| 80 | hepatocyte apoptotic process (GO:0097284) | 3.13613533 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 3.13167805 |
| 82 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.12887651 |
| 83 | valine metabolic process (GO:0006573) | 3.12489294 |
| 84 | cellular amino acid catabolic process (GO:0009063) | 3.12100706 |
| 85 | regulation of protein activation cascade (GO:2000257) | 3.12040537 |
| 86 | coenzyme catabolic process (GO:0009109) | 3.11945130 |
| 87 | fatty acid catabolic process (GO:0009062) | 3.11696044 |
| 88 | negative regulation of B cell activation (GO:0050869) | 3.10418120 |
| 89 | respiratory chain complex IV assembly (GO:0008535) | 3.09749936 |
| 90 | drug transmembrane transport (GO:0006855) | 3.07506613 |
| 91 | drug catabolic process (GO:0042737) | 3.07209253 |
| 92 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.06256417 |
| 93 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.06256417 |
| 94 | T cell differentiation involved in immune response (GO:0002292) | 3.06256417 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 3.05526626 |
| 96 | negative regulation of fibrinolysis (GO:0051918) | 3.05393266 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.05070714 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.05070714 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 3.04713488 |
| 100 | regulation of fibrinolysis (GO:0051917) | 3.04667286 |
| 101 | ER overload response (GO:0006983) | 3.04602834 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.04517046 |
| 103 | cholesterol efflux (GO:0033344) | 3.03175532 |
| 104 | intestinal absorption (GO:0050892) | 3.02722619 |
| 105 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02315569 |
| 106 | monocarboxylic acid catabolic process (GO:0072329) | 3.01191067 |
| 107 | axoneme assembly (GO:0035082) | 3.00638162 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00506158 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00506158 |
| 110 | glutamate metabolic process (GO:0006536) | 2.99662381 |
| 111 | S-adenosylmethionine metabolic process (GO:0046500) | 2.99486633 |
| 112 | regulation of cholesterol metabolic process (GO:0090181) | 2.98800883 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 2.97285670 |
| 114 | benzene-containing compound metabolic process (GO:0042537) | 2.96499785 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 2.95343483 |
| 116 | regulation of acrosome reaction (GO:0060046) | 2.94947313 |
| 117 | very long-chain fatty acid metabolic process (GO:0000038) | 2.94874204 |
| 118 | regulation of complement activation (GO:0030449) | 2.93820848 |
| 119 | cholesterol homeostasis (GO:0042632) | 2.92918681 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 2.92665799 |
| 121 | organic acid catabolic process (GO:0016054) | 2.92665799 |
| 122 | branched-chain amino acid catabolic process (GO:0009083) | 2.92588896 |
| 123 | bile acid and bile salt transport (GO:0015721) | 2.92523653 |
| 124 | negative regulation of B cell proliferation (GO:0030889) | 2.91994796 |
| 125 | * regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.91622644 |
| 126 | * positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.91622644 |
| 127 | flavonoid metabolic process (GO:0009812) | 2.89674231 |
| 128 | nucleotide transmembrane transport (GO:1901679) | 2.89481964 |
| 129 | sterol homeostasis (GO:0055092) | 2.89335595 |
| 130 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.89098273 |
| 131 | endocrine pancreas development (GO:0031018) | 2.87957516 |
| 132 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.87581043 |
| 133 | negative regulation of cholesterol transport (GO:0032375) | 2.85915620 |
| 134 | negative regulation of sterol transport (GO:0032372) | 2.85915620 |
| 135 | xenobiotic catabolic process (GO:0042178) | 2.83874463 |
| 136 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82960175 |
| 137 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82960175 |
| 138 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.81679022 |
| 139 | transcytosis (GO:0045056) | 2.81245934 |
| 140 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81195104 |
| 141 | ketone body metabolic process (GO:1902224) | 2.81114149 |
| 142 | branched-chain amino acid metabolic process (GO:0009081) | 2.80250937 |
| 143 | indolalkylamine metabolic process (GO:0006586) | 2.79639814 |
| 144 | carnitine metabolic process (GO:0009437) | 2.79639567 |
| 145 | biotin metabolic process (GO:0006768) | 2.79152569 |
| 146 | auditory receptor cell stereocilium organization (GO:0060088) | 2.77396046 |
| 147 | positive regulation of fatty acid oxidation (GO:0046321) | 2.76599215 |
| 148 | alpha-beta T cell differentiation (GO:0046632) | 2.72261810 |
| 149 | signal peptide processing (GO:0006465) | 2.66451348 |
| 150 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.65006699 |
| 151 | female gonad development (GO:0008585) | 2.64946570 |
| 152 | cytochrome complex assembly (GO:0017004) | 2.63826456 |
| 153 | positive regulation of glycolytic process (GO:0045821) | 2.63457293 |
| 154 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.56813203 |
| 155 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.55597936 |
| 156 | photoreceptor cell development (GO:0042461) | 2.54324855 |
| 157 | eye photoreceptor cell development (GO:0042462) | 2.52409323 |
| 158 | cytidine deamination (GO:0009972) | 2.51669213 |
| 159 | cytidine metabolic process (GO:0046087) | 2.51669213 |
| 160 | cytidine catabolic process (GO:0006216) | 2.51669213 |
| 161 | regulation of protein autophosphorylation (GO:0031952) | 2.51310251 |
| 162 | cellular response to interleukin-15 (GO:0071350) | 2.49280942 |
| 163 | regulation of memory T cell differentiation (GO:0043380) | 2.47708469 |
| 164 | protein localization to cilium (GO:0061512) | 2.46085081 |
| 165 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.45121980 |
| 166 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.44152496 |
| 167 | inositol phosphate catabolic process (GO:0071545) | 2.43926219 |
| 168 | multicellular organism reproduction (GO:0032504) | 2.43305042 |
| 169 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.42585219 |
| 170 | neural tube formation (GO:0001841) | 2.41429004 |
| 171 | polyol catabolic process (GO:0046174) | 2.40753232 |
| 172 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.39758018 |
| 173 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.39758018 |
| 174 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.39758018 |
| 175 | * regulation of mRNA catabolic process (GO:0061013) | 2.36259854 |
| 176 | negative regulation of neurological system process (GO:0031645) | 2.35809556 |
| 177 | regulation of relaxation of muscle (GO:1901077) | 2.35538520 |
| 178 | alpha-beta T cell activation (GO:0046631) | 2.34943229 |
| 179 | retinal metabolic process (GO:0042574) | 2.34745956 |
| 180 | transepithelial transport (GO:0070633) | 2.34697057 |
| 181 | zinc ion transport (GO:0006829) | 2.32186120 |
| 182 | regulation of autophagic vacuole assembly (GO:2000785) | 2.32008745 |
| 183 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.31334026 |
| 184 | negative T cell selection (GO:0043383) | 2.30337441 |
| 185 | estrogen metabolic process (GO:0008210) | 2.30212958 |
| 186 | fucose catabolic process (GO:0019317) | 2.28349607 |
| 187 | L-fucose metabolic process (GO:0042354) | 2.28349607 |
| 188 | L-fucose catabolic process (GO:0042355) | 2.28349607 |
| 189 | cellular response to glucocorticoid stimulus (GO:0071385) | 2.28315060 |
| 190 | embryonic epithelial tube formation (GO:0001838) | 2.27940564 |
| 191 | piRNA metabolic process (GO:0034587) | 2.27931944 |
| 192 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.26524014 |
| 193 | regulation of meiosis I (GO:0060631) | 2.25883739 |
| 194 | C-terminal protein lipidation (GO:0006501) | 2.25533593 |
| 195 | positive regulation of organelle assembly (GO:1902117) | 2.24517931 |
| 196 | adaptation of signaling pathway (GO:0023058) | 2.24454744 |
| 197 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.23467222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.38145955 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84571902 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.14406285 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.14194889 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.70228295 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.41523937 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.37500234 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.37401721 |
| 9 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.10887184 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71506285 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.55069612 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52840267 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.45126553 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44359287 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43574918 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27191129 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.17714925 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.14168510 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10599185 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.07625372 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.07483955 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97159775 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92175976 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88544933 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.88024251 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.85232731 |
| 27 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.78669735 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.77283210 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76325007 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74364126 |
| 31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.72241529 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70425375 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68927348 |
| 34 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68835257 |
| 35 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68542454 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67442193 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63984007 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63588586 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59190703 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56293508 |
| 41 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.55272879 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.55270369 |
| 43 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54986532 |
| 44 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47545817 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45692740 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45493368 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45395149 |
| 48 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45107645 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44826765 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44575588 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44499664 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41913274 |
| 53 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.41905144 |
| 54 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.41905144 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41620846 |
| 56 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.39965628 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39851387 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39851387 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39014172 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.38916633 |
| 61 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.38429545 |
| 62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.38157013 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.37336040 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37192280 |
| 65 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36287709 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34764610 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31310350 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27195476 |
| 69 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27195476 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26681790 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26345117 |
| 72 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24980640 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24793866 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24158507 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22973209 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22718286 |
| 77 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22408201 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21971640 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21633502 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19683509 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19631525 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.19373509 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19366538 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19262305 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19260736 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.18904882 |
| 87 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18637879 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18612040 |
| 89 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.18237387 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17206852 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16993398 |
| 92 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16424910 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15682064 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14883265 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14860539 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14404289 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14345252 |
| 98 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13939367 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13323572 |
| 100 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12641957 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12596435 |
| 102 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12320155 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12112978 |
| 104 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11957304 |
| 105 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11650781 |
| 106 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11224158 |
| 107 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.10831532 |
| 108 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09442430 |
| 109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07313264 |
| 110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07070501 |
| 111 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.07066793 |
| 112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05770493 |
| 113 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05296041 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04507241 |
| 115 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.03543372 |
| 116 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03152549 |
| 117 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02855211 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02718170 |
| 119 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02345015 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02235657 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01327615 |
| 122 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99877615 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99870673 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97107286 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96715308 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94656717 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91021179 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90133704 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89970489 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88886894 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88781822 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87902473 |
| 133 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87345523 |
| 134 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87345523 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86250730 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85367596 |
| 137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84414042 |
| 138 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84068118 |
| 139 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83522532 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82991101 |
| 141 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.82949369 |
| 142 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82890895 |
| 143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82129064 |
| 144 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80583443 |
| 145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80423655 |
| 146 | VDR_22108803_ChIP-Seq_LS180_Human | 0.80405790 |
| 147 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79042452 |
| 148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.78856963 |
| 149 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.77845942 |
| 150 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77332727 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76865636 |
| 152 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76265308 |
| 153 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75369873 |
| 154 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74814373 |
| 155 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.74406604 |
| 156 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74399187 |
| 157 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.74192854 |
| 158 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73466708 |
| 159 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72116766 |
| 160 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.69608204 |
| 161 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68472959 |
| 162 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67605836 |
| 163 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67553757 |
| 164 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67458999 |
| 165 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67333468 |
| 166 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67152963 |
| 167 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66617148 |
| 168 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.66148160 |
| 169 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65700547 |
| 170 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65479636 |
| 171 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.64377440 |
| 172 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.63859664 |
| 173 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.63628179 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62754071 |
| 175 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.62365333 |
| 176 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62365061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.29591952 |
| 2 | MP0005360_urolithiasis | 5.86500563 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.07459833 |
| 4 | MP0005365_abnormal_bile_salt | 4.93685546 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.09761868 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.25307797 |
| 7 | MP0000427_abnormal_hair_cycle | 3.08116474 |
| 8 | MP0003252_abnormal_bile_duct | 3.05422529 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.98042382 |
| 10 | MP0003195_calcinosis | 2.95354728 |
| 11 | MP0005083_abnormal_biliary_tract | 2.90470308 |
| 12 | MP0002009_preneoplasia | 2.82965558 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.76938885 |
| 14 | MP0003787_abnormal_imprinting | 2.76437894 |
| 15 | MP0002163_abnormal_gland_morphology | 2.69915565 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.55359965 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.47958693 |
| 18 | MP0005332_abnormal_amino_acid | 2.43504542 |
| 19 | MP0000372_irregular_coat_pigmentation | 2.39430349 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 2.36303116 |
| 21 | MP0008995_early_reproductive_senescence | 2.22006893 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.13000978 |
| 23 | MP0009840_abnormal_foam_cell | 2.09346423 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.07983425 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 2.07679217 |
| 26 | MP0008872_abnormal_physiological_respon | 1.90742757 |
| 27 | MP0001919_abnormal_reproductive_system | 1.90519667 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.89159380 |
| 29 | MP0004043_abnormal_pH_regulation | 1.74910953 |
| 30 | MP0006072_abnormal_retinal_apoptosis | 1.72657586 |
| 31 | MP0008057_abnormal_DNA_replication | 1.72070123 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.71947532 |
| 33 | MP0002254_reproductive_system_inflammat | 1.68783357 |
| 34 | MP0003786_premature_aging | 1.68326158 |
| 35 | MP0003868_abnormal_feces_composition | 1.62029967 |
| 36 | MP0002006_tumorigenesis | 1.58820413 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.57171433 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.56373568 |
| 39 | MP0000609_abnormal_liver_physiology | 1.56323600 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.52660329 |
| 41 | MP0002796_impaired_skin_barrier | 1.52291607 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.49366806 |
| 43 | MP0002102_abnormal_ear_morphology | 1.48513647 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.48269027 |
| 45 | MP0001984_abnormal_olfaction | 1.44564260 |
| 46 | MP0004130_abnormal_muscle_cell | 1.41687622 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.41590474 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.40326181 |
| 49 | MP0005389_reproductive_system_phenotype | 1.39226156 |
| 50 | MP0005671_abnormal_response_to | 1.38356728 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.36877294 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.36426514 |
| 53 | MP0005670_abnormal_white_adipose | 1.35227283 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.34460501 |
| 55 | MP0005253_abnormal_eye_physiology | 1.33819125 |
| 56 | MP0005451_abnormal_body_composition | 1.29668752 |
| 57 | MP0006054_spinal_hemorrhage | 1.24650631 |
| 58 | MP0005367_renal/urinary_system_phenotyp | 1.24405531 |
| 59 | MP0000516_abnormal_urinary_system | 1.24405531 |
| 60 | MP0002938_white_spotting | 1.22387290 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.20097509 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.19575189 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18318600 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.17729168 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.17577201 |
| 66 | MP0005220_abnormal_exocrine_pancreas | 1.17385361 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.16927665 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.16608514 |
| 69 | MP0002971_abnormal_brown_adipose | 1.13933690 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.12980384 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.11053985 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.10074716 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.08394305 |
| 74 | MP0000569_abnormal_digit_pigmentation | 1.07236575 |
| 75 | MP0001243_abnormal_dermal_layer | 1.06004612 |
| 76 | MP0005647_abnormal_sex_gland | 1.04529848 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.04387338 |
| 78 | MP0001764_abnormal_homeostasis | 1.04014638 |
| 79 | MP0000579_abnormal_nail_morphology | 1.03884715 |
| 80 | MP0003011_delayed_dark_adaptation | 1.01155458 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.99806556 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.98868696 |
| 83 | MP0009785_altered_susceptibility_to | 0.96464528 |
| 84 | MP0003690_abnormal_glial_cell | 0.95517661 |
| 85 | MP0002060_abnormal_skin_morphology | 0.94516107 |
| 86 | MP0005408_hypopigmentation | 0.94497088 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.93782157 |
| 88 | MP0005410_abnormal_fertilization | 0.93169781 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.93103917 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.93027891 |
| 91 | MP0003186_abnormal_redox_activity | 0.92114630 |
| 92 | MP0005334_abnormal_fat_pad | 0.92008942 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.90653434 |
| 94 | MP0001853_heart_inflammation | 0.90224491 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.89557382 |
| 96 | MP0004381_abnormal_hair_follicle | 0.89549092 |
| 97 | MP0002098_abnormal_vibrissa_morphology | 0.87394794 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.87037114 |
| 99 | MP0005310_abnormal_salivary_gland | 0.86603612 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.80580694 |
| 101 | MP0005535_abnormal_body_temperature | 0.79860362 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.79837896 |
| 103 | MP0002557_abnormal_social/conspecific_i | 0.79387450 |
| 104 | MP0001929_abnormal_gametogenesis | 0.78455999 |
| 105 | MP0002160_abnormal_reproductive_system | 0.78274111 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.77706841 |
| 107 | MP0001661_extended_life_span | 0.77579159 |
| 108 | MP0002928_abnormal_bile_duct | 0.76933368 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.76714322 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.76455889 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.76132335 |
| 112 | MP0000653_abnormal_sex_gland | 0.75353909 |
| 113 | MP0001756_abnormal_urination | 0.75348224 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.75065292 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.74700482 |
| 116 | MP0003724_increased_susceptibility_to | 0.73566353 |
| 117 | MP0005275_abnormal_skin_tensile | 0.73434589 |
| 118 | MP0000647_abnormal_sebaceous_gland | 0.73064724 |
| 119 | MP0005448_abnormal_energy_balance | 0.72440591 |
| 120 | MP0001485_abnormal_pinna_reflex | 0.72380459 |
| 121 | MP0000383_abnormal_hair_follicle | 0.72260177 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.72028148 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.71042221 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.70551518 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.70030425 |
| 126 | MP0010678_abnormal_skin_adnexa | 0.69682585 |
| 127 | MP0001119_abnormal_female_reproductive | 0.68403248 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.68102895 |
| 129 | MP0003329_amyloid_beta_deposits | 0.67916784 |
| 130 | MP0002090_abnormal_vision | 0.67025849 |
| 131 | MP0003878_abnormal_ear_physiology | 0.65731110 |
| 132 | MP0005377_hearing/vestibular/ear_phenot | 0.65731110 |
| 133 | MP0000538_abnormal_urinary_bladder | 0.65455778 |
| 134 | MP0000566_synostosis | 0.65346960 |
| 135 | MP0000749_muscle_degeneration | 0.65181651 |
| 136 | MP0003959_abnormal_lean_body | 0.64427126 |
| 137 | MP0009764_decreased_sensitivity_to | 0.64055233 |
| 138 | MP0001873_stomach_inflammation | 0.63971123 |
| 139 | MP0000467_abnormal_esophagus_morphology | 0.63971101 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.63373098 |
| 141 | MP0005248_abnormal_Harderian_gland | 0.62910952 |
| 142 | MP0001881_abnormal_mammary_gland | 0.61360901 |
| 143 | MP0003656_abnormal_erythrocyte_physiolo | 0.59894214 |
| 144 | MP0000613_abnormal_salivary_gland | 0.59321366 |
| 145 | MP0001800_abnormal_humoral_immune | 0.59181284 |
| 146 | MP0000920_abnormal_myelination | 0.58892524 |
| 147 | MP0008961_abnormal_basal_metabolism | 0.58853680 |
| 148 | MP0000762_abnormal_tongue_morphology | 0.58780548 |
| 149 | MP0000598_abnormal_liver_morphology | 0.57958133 |
| 150 | MP0003300_gastrointestinal_ulcer | 0.57941991 |
| 151 | MP0003953_abnormal_hormone_level | 0.57597404 |
| 152 | MP0000377_abnormal_hair_follicle | 0.57142354 |
| 153 | MP0000604_amyloidosis | 0.56332921 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.56272077 |
| 155 | MP0005330_cardiomyopathy | 0.55293059 |
| 156 | MP0009697_abnormal_copulation | 0.54554887 |
| 157 | MP0000747_muscle_weakness | 0.54299770 |
| 158 | MP0002108_abnormal_muscle_morphology | 0.54081181 |
| 159 | MP0005501_abnormal_skin_physiology | 0.53421437 |
| 160 | MP0006036_abnormal_mitochondrial_physio | 0.53265363 |
| 161 | MP0000639_abnormal_adrenal_gland | 0.52808550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77942642 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.63742541 |
| 3 | Xanthomatosis (HP:0000991) | 4.90303820 |
| 4 | Metaphyseal dysplasia (HP:0100255) | 4.80144837 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.79275286 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.41920914 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.36616467 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.19802150 |
| 9 | Hypothermia (HP:0002045) | 4.13022297 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.08470680 |
| 11 | Ketosis (HP:0001946) | 4.01843897 |
| 12 | Epidermoid cyst (HP:0200040) | 3.90398120 |
| 13 | Hyperglycinuria (HP:0003108) | 3.88793330 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.88382883 |
| 15 | Ketoacidosis (HP:0001993) | 3.72228521 |
| 16 | Fat malabsorption (HP:0002630) | 3.70114938 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.65978458 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63464702 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.63464702 |
| 20 | Hyperammonemia (HP:0001987) | 3.60368806 |
| 21 | Large for gestational age (HP:0001520) | 3.60227564 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44513904 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.40675560 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.39987417 |
| 25 | Hyperglycinemia (HP:0002154) | 3.37102613 |
| 26 | Stomatitis (HP:0010280) | 3.33625573 |
| 27 | Hypoglycemic seizures (HP:0002173) | 3.28412481 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.26375214 |
| 29 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.25321107 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24270518 |
| 31 | Complement deficiency (HP:0004431) | 3.22426979 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22350618 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.18148576 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14904007 |
| 35 | Gout (HP:0001997) | 3.14552512 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.14027188 |
| 37 | Abnormality of dental color (HP:0011073) | 3.13078968 |
| 38 | Thyroiditis (HP:0100646) | 3.08764847 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.03087358 |
| 40 | Abnormality of the renal cortex (HP:0011035) | 3.01141516 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.00487924 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.90912989 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87845777 |
| 44 | Vascular calcification (HP:0004934) | 2.85075702 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 2.83436000 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.78203319 |
| 47 | Pancreatic cysts (HP:0001737) | 2.77416793 |
| 48 | Steatorrhea (HP:0002570) | 2.77344330 |
| 49 | Joint hemorrhage (HP:0005261) | 2.77184793 |
| 50 | Breast carcinoma (HP:0003002) | 2.61673907 |
| 51 | Symptomatic seizures (HP:0011145) | 2.57870846 |
| 52 | Congenital stationary night blindness (HP:0007642) | 2.56953295 |
| 53 | Exercise-induced myalgia (HP:0003738) | 2.56123919 |
| 54 | Medial flaring of the eyebrow (HP:0010747) | 2.55237862 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.53876062 |
| 56 | Concave nail (HP:0001598) | 2.53507609 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 2.53040750 |
| 58 | Hydroxyprolinuria (HP:0003080) | 2.53040750 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.52174304 |
| 60 | Myocardial infarction (HP:0001658) | 2.51817370 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50733529 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.50733529 |
| 63 | Metabolic acidosis (HP:0001942) | 2.48137657 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.47690482 |
| 65 | Disproportionate short-trunk short stature (HP:0003521) | 2.45452012 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.45081714 |
| 67 | Hyperglycemia (HP:0003074) | 2.44128114 |
| 68 | Abnormality of midbrain morphology (HP:0002418) | 2.41032828 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 2.41032828 |
| 70 | True hermaphroditism (HP:0010459) | 2.40385882 |
| 71 | Myoglobinuria (HP:0002913) | 2.39645970 |
| 72 | Hypomagnesemia (HP:0002917) | 2.38511133 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.37387270 |
| 74 | Hyperuricemia (HP:0002149) | 2.35975264 |
| 75 | Increased purine levels (HP:0004368) | 2.35975264 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.30725232 |
| 77 | Hypokalemic alkalosis (HP:0001949) | 2.28207285 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 2.25070897 |
| 79 | Hyperbilirubinemia (HP:0002904) | 2.23971267 |
| 80 | Fair hair (HP:0002286) | 2.21555743 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.20351100 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 2.19119432 |
| 83 | Acute necrotizing encephalopathy (HP:0006965) | 2.18041289 |
| 84 | Pancreatitis (HP:0001733) | 2.17041763 |
| 85 | Albinism (HP:0001022) | 2.16667077 |
| 86 | Tongue fasciculations (HP:0001308) | 2.16174871 |
| 87 | Stomach cancer (HP:0012126) | 2.12821773 |
| 88 | Abnormality of complement system (HP:0005339) | 2.12566543 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 2.12308220 |
| 90 | Neonatal respiratory distress (HP:0002643) | 2.10712071 |
| 91 | Lethargy (HP:0001254) | 2.09302717 |
| 92 | Hepatocellular carcinoma (HP:0001402) | 2.09000106 |
| 93 | Abnormality of T cell number (HP:0011839) | 2.07837596 |
| 94 | Methylmalonic acidemia (HP:0002912) | 2.06835716 |
| 95 | Attenuation of retinal blood vessels (HP:0007843) | 2.06423552 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 2.06265204 |
| 97 | Hepatic necrosis (HP:0002605) | 2.05690729 |
| 98 | Metabolic alkalosis (HP:0200114) | 2.05598866 |
| 99 | Late onset (HP:0003584) | 2.05396296 |
| 100 | Skin nodule (HP:0200036) | 2.04426115 |
| 101 | Pigmentary retinal degeneration (HP:0001146) | 2.04280824 |
| 102 | Severe combined immunodeficiency (HP:0004430) | 2.04048969 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 2.03831681 |
| 104 | Short middle phalanx of the 5th finger (HP:0004220) | 2.01949725 |
| 105 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00557633 |
| 106 | Abnormality of the prostate (HP:0008775) | 2.00192655 |
| 107 | Hypoproteinemia (HP:0003075) | 2.00177764 |
| 108 | Posterior subcapsular cataract (HP:0007787) | 1.99965609 |
| 109 | Rickets (HP:0002748) | 1.99755301 |
| 110 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.99237869 |
| 111 | Hamartoma of the eye (HP:0010568) | 1.97344548 |
| 112 | Abnormality of serum amino acid levels (HP:0003112) | 1.96074327 |
| 113 | Malnutrition (HP:0004395) | 1.95296067 |
| 114 | Nephronophthisis (HP:0000090) | 1.95194150 |
| 115 | Patchy hypopigmentation of hair (HP:0011365) | 1.94978867 |
| 116 | Hyperkalemia (HP:0002153) | 1.94501870 |
| 117 | Mitochondrial inheritance (HP:0001427) | 1.94321946 |
| 118 | Febrile seizures (HP:0002373) | 1.93930254 |
| 119 | Acute encephalopathy (HP:0006846) | 1.93716529 |
| 120 | Renal cortical cysts (HP:0000803) | 1.93515783 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.93169597 |
| 122 | Exercise-induced muscle cramps (HP:0003710) | 1.92234862 |
| 123 | Alveolar cell carcinoma (HP:0006519) | 1.91339407 |
| 124 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90360069 |
| 125 | Increased CSF lactate (HP:0002490) | 1.90254681 |
| 126 | Hypoplastic iliac wings (HP:0002866) | 1.90006953 |
| 127 | Alopecia of scalp (HP:0002293) | 1.90006952 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.89918501 |
| 129 | Abnormality of the renal medulla (HP:0100957) | 1.89796794 |
| 130 | Male pseudohermaphroditism (HP:0000037) | 1.87954670 |
| 131 | Follicular hyperkeratosis (HP:0007502) | 1.87938035 |
| 132 | Enlarged kidneys (HP:0000105) | 1.87744078 |
| 133 | Lip pit (HP:0100267) | 1.87554563 |
| 134 | Barrel-shaped chest (HP:0001552) | 1.86125434 |
| 135 | Abnormality of vitamin metabolism (HP:0100508) | 1.85345306 |
| 136 | Alkalosis (HP:0001948) | 1.84745497 |
| 137 | Axonal loss (HP:0003447) | 1.84413137 |
| 138 | Neurofibrillary tangles (HP:0002185) | 1.83949079 |
| 139 | Esophageal varix (HP:0002040) | 1.83236866 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83086344 |
| 141 | Ileus (HP:0002595) | 1.82736919 |
| 142 | Chronic diarrhea (HP:0002028) | 1.82704310 |
| 143 | Cholelithiasis (HP:0001081) | 1.82274337 |
| 144 | IgG deficiency (HP:0004315) | 1.81901404 |
| 145 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81271880 |
| 146 | Increased circulating renin level (HP:0000848) | 1.80846305 |
| 147 | Abnormal tarsal ossification (HP:0008369) | 1.80605300 |
| 148 | Protuberant abdomen (HP:0001538) | 1.80530353 |
| 149 | Irritability (HP:0000737) | 1.79440413 |
| 150 | Abnormality of eosinophils (HP:0001879) | 1.78817479 |
| 151 | Abnormality of vitamin B metabolism (HP:0004340) | 1.78746409 |
| 152 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78686545 |
| 153 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78686545 |
| 154 | Hypoplasia of the odontoid process (HP:0003311) | 1.78529338 |
| 155 | Congenital primary aphakia (HP:0007707) | 1.78342248 |
| 156 | Type I diabetes mellitus (HP:0100651) | 1.78109564 |
| 157 | Abnormality of the pons (HP:0007361) | 1.77239755 |
| 158 | Abnormality of the 2nd finger (HP:0004100) | 1.76815721 |
| 159 | Vomiting (HP:0002013) | 1.76729090 |
| 160 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.74618999 |
| 161 | Proximal tubulopathy (HP:0000114) | 1.73945047 |
| 162 | Abnormal drinking behavior (HP:0030082) | 1.73882459 |
| 163 | Polydipsia (HP:0001959) | 1.73882459 |
| 164 | Glomerulosclerosis (HP:0000096) | 1.73799473 |
| 165 | Pulmonary infiltrates (HP:0002113) | 1.72871524 |
| 166 | Glycosuria (HP:0003076) | 1.71891169 |
| 167 | Abnormality of urine glucose concentration (HP:0011016) | 1.71891169 |
| 168 | Chronic hepatic failure (HP:0100626) | 1.71840331 |
| 169 | Sensorimotor neuropathy (HP:0007141) | 1.71631959 |
| 170 | Curly hair (HP:0002212) | 1.71256518 |
| 171 | Polyuria (HP:0000103) | 1.71077735 |
| 172 | Acanthosis nigricans (HP:0000956) | 1.70417591 |
| 173 | Gait imbalance (HP:0002141) | 1.69929584 |
| 174 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.69091477 |
| 175 | Respiratory distress (HP:0002098) | 1.68918582 |
| 176 | Hyperventilation (HP:0002883) | 1.68472061 |
| 177 | Muscle fiber splitting (HP:0003555) | 1.68346858 |
| 178 | Tubular atrophy (HP:0000092) | 1.68248393 |
| 179 | Intestinal atresia (HP:0011100) | 1.68089654 |
| 180 | Hypoplasia of the fovea (HP:0007750) | 1.67850646 |
| 181 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.67850646 |
| 182 | Abolished electroretinogram (ERG) (HP:0000550) | 1.67581679 |
| 183 | Hemorrhage of the eye (HP:0011885) | 1.67554101 |
| 184 | Amyloidosis (HP:0011034) | 1.67054452 |
| 185 | Muscle fiber inclusion bodies (HP:0100299) | 1.67013408 |
| 186 | Confusion (HP:0001289) | 1.66549360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.83260215 |
| 2 | BRSK2 | 3.59290075 |
| 3 | MAPK15 | 3.45509589 |
| 4 | ERBB3 | 3.19773098 |
| 5 | SIK1 | 3.12505513 |
| 6 | INSRR | 3.11629747 |
| 7 | TRIM28 | 2.85899185 |
| 8 | SIK3 | 2.57539711 |
| 9 | EIF2AK3 | 2.54365284 |
| 10 | EPHB1 | 2.52736401 |
| 11 | WEE1 | 2.51975021 |
| 12 | ERN1 | 2.45712430 |
| 13 | LATS1 | 2.24979401 |
| 14 | WNK4 | 2.21625019 |
| 15 | FRK | 2.20378053 |
| 16 | CASK | 2.02487584 |
| 17 | STK39 | 2.02298507 |
| 18 | MST1R | 1.88338716 |
| 19 | MAP2K2 | 1.87257033 |
| 20 | MAP3K12 | 1.86465055 |
| 21 | PIK3CG | 1.72702901 |
| 22 | FGFR4 | 1.70371724 |
| 23 | OBSCN | 1.69019907 |
| 24 | FGFR2 | 1.67692626 |
| 25 | MAP3K3 | 1.61575488 |
| 26 | BMPR2 | 1.58967203 |
| 27 | MST4 | 1.58019250 |
| 28 | MET | 1.53176261 |
| 29 | ERBB4 | 1.46198619 |
| 30 | TSSK6 | 1.45138877 |
| 31 | OXSR1 | 1.41604786 |
| 32 | TAOK3 | 1.33942627 |
| 33 | TEC | 1.30281216 |
| 34 | PHKG2 | 1.25274192 |
| 35 | PHKG1 | 1.25274192 |
| 36 | IRAK3 | 1.25064280 |
| 37 | PRKCI | 1.23542196 |
| 38 | IKBKB | 1.23264001 |
| 39 | MAP3K2 | 1.22313242 |
| 40 | PIK3CA | 1.19187589 |
| 41 | PRKAA2 | 1.18444019 |
| 42 | PTK6 | 1.17367479 |
| 43 | TRIB3 | 1.17085530 |
| 44 | TXK | 1.16660778 |
| 45 | ADRBK2 | 1.15614415 |
| 46 | BRSK1 | 1.15408292 |
| 47 | MKNK2 | 1.14511761 |
| 48 | SGK223 | 1.09414152 |
| 49 | SGK494 | 1.09414152 |
| 50 | MAP4K2 | 1.09087109 |
| 51 | PKN1 | 1.06988622 |
| 52 | STK10 | 1.04725559 |
| 53 | EPHA3 | 1.04324206 |
| 54 | STK38L | 1.03895205 |
| 55 | IRAK1 | 1.01530614 |
| 56 | GRK1 | 1.01491716 |
| 57 | FER | 1.01038463 |
| 58 | EPHB2 | 1.00445882 |
| 59 | MAP3K7 | 0.99312924 |
| 60 | RIPK1 | 0.98255050 |
| 61 | PAK3 | 0.98254370 |
| 62 | GSK3A | 0.97969631 |
| 63 | PINK1 | 0.91741153 |
| 64 | IRAK2 | 0.91290145 |
| 65 | TIE1 | 0.91042044 |
| 66 | CAMK1G | 0.89656552 |
| 67 | PDK2 | 0.88212190 |
| 68 | CAMK1D | 0.86690135 |
| 69 | CHUK | 0.83940675 |
| 70 | DYRK1B | 0.82795808 |
| 71 | PTK2 | 0.81521655 |
| 72 | AKT3 | 0.79499691 |
| 73 | CAMK2G | 0.77547280 |
| 74 | NLK | 0.77250632 |
| 75 | WNK3 | 0.77157137 |
| 76 | DMPK | 0.76646259 |
| 77 | PRKD1 | 0.76501134 |
| 78 | BCR | 0.76324675 |
| 79 | EIF2AK1 | 0.76085362 |
| 80 | TNIK | 0.75287194 |
| 81 | WNK1 | 0.74184467 |
| 82 | SGK3 | 0.74155339 |
| 83 | ACVR1B | 0.74152917 |
| 84 | SGK2 | 0.73328861 |
| 85 | PLK2 | 0.73130218 |
| 86 | GRK6 | 0.71551469 |
| 87 | MAP2K1 | 0.71140730 |
| 88 | PRKAA1 | 0.69301507 |
| 89 | MUSK | 0.69105260 |
| 90 | MAPK12 | 0.66631648 |
| 91 | MAPK7 | 0.66407392 |
| 92 | HIPK2 | 0.64525841 |
| 93 | NEK9 | 0.64475354 |
| 94 | MARK3 | 0.62420405 |
| 95 | MAP3K1 | 0.61287694 |
| 96 | BRD4 | 0.60812140 |
| 97 | STK3 | 0.60452948 |
| 98 | TTN | 0.59588753 |
| 99 | ZAK | 0.59026200 |
| 100 | TLK1 | 0.56029915 |
| 101 | PNCK | 0.54956300 |
| 102 | TRPM7 | 0.54940535 |
| 103 | CAMK2D | 0.54803484 |
| 104 | NUAK1 | 0.54464250 |
| 105 | JAK1 | 0.53848336 |
| 106 | BMPR1B | 0.53723885 |
| 107 | PRKG2 | 0.53687889 |
| 108 | MAPKAPK5 | 0.53683227 |
| 109 | NEK6 | 0.53553112 |
| 110 | EPHA2 | 0.53542673 |
| 111 | CDK8 | 0.53447993 |
| 112 | MAPK11 | 0.52903572 |
| 113 | DDR2 | 0.52050043 |
| 114 | CSK | 0.51528023 |
| 115 | PBK | 0.51424591 |
| 116 | NME1 | 0.51122045 |
| 117 | LMTK2 | 0.51081466 |
| 118 | PRKCE | 0.49637137 |
| 119 | PDPK1 | 0.48742690 |
| 120 | MAP3K14 | 0.48475462 |
| 121 | JAK2 | 0.48029673 |
| 122 | TYK2 | 0.47672454 |
| 123 | FGFR3 | 0.45607633 |
| 124 | PRKACG | 0.43170407 |
| 125 | PRKCQ | 0.42855083 |
| 126 | ABL1 | 0.42507439 |
| 127 | MAPKAPK3 | 0.42506628 |
| 128 | MAP2K4 | 0.42138859 |
| 129 | CAMK2B | 0.41362523 |
| 130 | TGFBR2 | 0.41233368 |
| 131 | ITK | 0.39789623 |
| 132 | CAMKK2 | 0.39749456 |
| 133 | IKBKE | 0.39747996 |
| 134 | MAP2K6 | 0.39676684 |
| 135 | CSNK1G1 | 0.39573637 |
| 136 | ERBB2 | 0.37477423 |
| 137 | DYRK1A | 0.36777638 |
| 138 | NTRK1 | 0.36574446 |
| 139 | IGF1R | 0.35750871 |
| 140 | MYLK | 0.35319224 |
| 141 | EIF2AK2 | 0.34407295 |
| 142 | ADRBK1 | 0.34343821 |
| 143 | STK24 | 0.33463241 |
| 144 | ROCK1 | 0.33088840 |
| 145 | PTK2B | 0.30203574 |
| 146 | DYRK3 | 0.29671147 |
| 147 | FGFR1 | 0.28527494 |
| 148 | EGFR | 0.27993604 |
| 149 | MAPK13 | 0.26839957 |
| 150 | RPS6KB1 | 0.26382452 |
| 151 | PRKCG | 0.24330885 |
| 152 | CSNK1G3 | 0.24197770 |
| 153 | PLK3 | 0.23310310 |
| 154 | TAF1 | 0.23220595 |
| 155 | CSNK1A1 | 0.22740109 |
| 156 | TNK2 | 0.21235755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22666220 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09043093 |
| 3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.73773936 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71617876 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59381870 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49264987 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.38203276 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35876881 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.32048385 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31133467 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.30440349 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21942734 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16437557 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08871394 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06356628 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01694074 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01605729 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00774715 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96805973 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91717546 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87513108 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.87500847 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87136730 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.82122248 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77852921 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76416494 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75769367 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75538017 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.75242020 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.74925302 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74377055 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74101417 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73592775 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.70695804 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67676022 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59254646 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58328675 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.54740032 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54361055 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52137840 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.47489161 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42129871 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35082308 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31963682 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30906659 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29888404 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29448900 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29025342 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28903290 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28149149 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26284752 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25951142 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24757709 |
| 54 | * RNA degradation_Homo sapiens_hsa03018 | 1.21711446 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21601811 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20052113 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 1.19541445 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18021393 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16346615 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.14148114 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10296538 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09738349 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06994886 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05886519 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 1.01973848 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01275823 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00659225 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98597124 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95833246 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88064717 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86057740 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.85634387 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84772221 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81165972 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78291029 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76952849 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75368697 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73789659 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70915277 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68947410 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68930663 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.68760726 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68413106 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.67984079 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67920424 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66672579 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64762063 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63929759 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62720556 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.62087545 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58039450 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57508214 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56891566 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56371626 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55631066 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55577405 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55299255 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.54262441 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52761092 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52147458 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51950848 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50340642 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.49938432 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49387085 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48536076 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.48058158 |
| 107 | Homologous recombination_Homo sapiens_hsa03440 | 0.43789211 |
| 108 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43663577 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43344940 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41792583 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39110230 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37747744 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35117420 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34494797 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34123954 |
| 116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33580554 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32146957 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31323826 |
| 119 | Protein export_Homo sapiens_hsa03060 | 0.31089195 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30958937 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30723144 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29975442 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29243465 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.26983860 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26775472 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25969901 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21200775 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.20585486 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.20381995 |
| 130 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19546087 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19508844 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16907242 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14776313 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14324228 |
| 135 | Insulin secretion_Homo sapiens_hsa04911 | 0.13626930 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.11797001 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.11794096 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.11320732 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10136588 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.08731253 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.06997286 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.06799717 |
| 143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05698471 |

